← Leaderboards
David Castro
Pdx Pharmaceuticals, Inc.
$1,200,000
Attributed
$1,200,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2013–14$1M$750K$500K$250K$0
'13
'14
Funding mix
By agency
NIH$1,200,000 · 1
By mechanism
N43$1,200,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Pdx Pharmaceuticals, Inc.
Same institution · by research overlap
- Worapol Ngamcherdtrakul$4,005,298
- Moataz Reda$570,260
Others in their field
Top investigators on “Accounting”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$185,928,938
- Zeljko Ivezic · University Of Washington$142,654,512
- Victor Krabbendam · Association Of Universities For Research In Astronomy, Inc.$142,654,512
- Steven M Kahn · Association Of Universities For Research In Astronomy, Inc.$142,654,512
Research focus
AccountingAdverse EffectsAreaArtificial NanoparticlesBiological AvailabilityBreast Cancer CellCancer CellCancer Cell LineCancer TherapyCellsCessation Of LifeDesignDiagnosisDrug ResistanceErbb2 GeneEvaluationGrowthGrowth Factor ReceptorsHybridsIn VitroIn VivoKnock-DownLapatinibLink